DK0817650T3 - Syntetiske peptider og farmaceutiske sammensætninger, der omfatter disse, til behandling af systemisk lupus erythematosus - Google Patents

Syntetiske peptider og farmaceutiske sammensætninger, der omfatter disse, til behandling af systemisk lupus erythematosus

Info

Publication number
DK0817650T3
DK0817650T3 DK96911449T DK96911449T DK0817650T3 DK 0817650 T3 DK0817650 T3 DK 0817650T3 DK 96911449 T DK96911449 T DK 96911449T DK 96911449 T DK96911449 T DK 96911449T DK 0817650 T3 DK0817650 T3 DK 0817650T3
Authority
DK
Denmark
Prior art keywords
treatment
pharmaceutical compositions
lupus erythematosus
systemic lupus
synthetic peptides
Prior art date
Application number
DK96911449T
Other languages
English (en)
Inventor
Edna Mozes
Ari Waisman
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Application granted granted Critical
Publication of DK0817650T3 publication Critical patent/DK0817650T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/643Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/74Inducing cell proliferation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/10Musculoskeletal or connective tissue disorders
    • G01N2800/101Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/104Lupus erythematosus [SLE]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/24Immunology or allergic disorders
DK96911449T 1995-03-28 1996-03-27 Syntetiske peptider og farmaceutiske sammensætninger, der omfatter disse, til behandling af systemisk lupus erythematosus DK0817650T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL11315995A IL113159A0 (en) 1995-03-28 1995-03-28 Synthetic peptides and pharmaceutical compositions comprising them
PCT/US1996/004206 WO1996030057A1 (en) 1995-03-28 1996-03-27 Synthetic peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus

Publications (1)

Publication Number Publication Date
DK0817650T3 true DK0817650T3 (da) 2004-03-08

Family

ID=11067281

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96911449T DK0817650T3 (da) 1995-03-28 1996-03-27 Syntetiske peptider og farmaceutiske sammensætninger, der omfatter disse, til behandling af systemisk lupus erythematosus

Country Status (11)

Country Link
EP (1) EP0817650B1 (da)
JP (1) JP3862752B2 (da)
AT (1) ATE253944T1 (da)
AU (1) AU706772B2 (da)
CA (1) CA2217776C (da)
DE (1) DE69630682T2 (da)
DK (1) DK0817650T3 (da)
ES (1) ES2212801T3 (da)
IL (2) IL113159A0 (da)
PT (1) PT817650E (da)
WO (1) WO1996030057A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6613536B1 (en) * 1995-03-28 2003-09-02 Yeda Research And Development Co. Ltd. Synthetic peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
US7488590B2 (en) 1998-10-23 2009-02-10 Amgen Inc. Modified peptides as therapeutic agents
MEP42108A (en) 1998-10-23 2011-02-10 Kiren Amgen Inc Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
IL141647A0 (en) * 2001-02-26 2002-03-10 Yeda Res & Dev Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
AU2003228084A1 (en) * 2002-05-28 2003-12-12 Omrix Biopharmaceuticals Inc. Method for obtaining anti-idiotype antibodies
CN1774259B (zh) * 2003-01-14 2011-12-28 特瓦制药工业有限公司 治疗系统性红斑狼疮的肽的胃肠道外制剂
UA83816C2 (ru) * 2003-01-14 2008-08-26 Тева Фармасьютикал Индастриз, Лтд ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, КОТОРАЯ СОДЕРЖИТ ПЕПТИД И ЗАМЕЩЕННЫЙ β-ЦИКЛОДЕКСТРИН, ДЛЯ ЛЕЧЕНИЯ СИСТЕМНОЙ КРАСНОЙ ВОЛЧАНКИ
EP1773400A2 (en) 2004-07-08 2007-04-18 Amgen Inc. Therapeutic peptides
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
US9283260B2 (en) 2006-04-21 2016-03-15 Amgen Inc. Lyophilized therapeutic peptibody formulations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992021367A1 (en) * 1991-05-31 1992-12-10 Arthur Allen Vandenbark T cell receptor peptides as therapeutics for immune-related disease

Also Published As

Publication number Publication date
DE69630682T2 (de) 2004-09-16
CA2217776C (en) 2004-12-07
WO1996030057A1 (en) 1996-10-03
AU5433496A (en) 1996-10-16
CA2217776A1 (en) 1996-10-03
IL117686A (en) 2000-10-31
JPH11503124A (ja) 1999-03-23
ES2212801T3 (es) 2004-08-01
DE69630682D1 (de) 2003-12-18
IL113159A0 (en) 1995-06-29
IL117686A0 (en) 1996-07-23
JP3862752B2 (ja) 2006-12-27
EP0817650A4 (en) 1999-09-01
AU706772B2 (en) 1999-06-24
EP0817650A1 (en) 1998-01-14
ATE253944T1 (de) 2003-11-15
EP0817650B1 (en) 2003-11-12
PT817650E (pt) 2004-03-31

Similar Documents

Publication Publication Date Title
CY1121451T1 (el) Ανθρωπινα μονοκλωνικα αντισωματα κατα του ctla-4
CY1107708T1 (el) Ανθρωπινα μονοκλωνικα αντισωματα για υποδοχεα παραγοντα επιδερμικης αναπτυξης
DE69327229T2 (de) Multivalente einkettige Antikörper
PT941121E (pt) Preparados farmaceuticos liofilizados, estaveis, de anticorpos monoclonais ou policlonais
TNSN93012A1 (fr) Conception, clonage et expression d'anticorps monoclonaux humanises contre l'interleukine-5 humaine
DK0817650T3 (da) Syntetiske peptider og farmaceutiske sammensætninger, der omfatter disse, til behandling af systemisk lupus erythematosus
DK0724456T3 (da) CD40-Antistoffer
ES2173130T3 (es) Metodo de fijacion de material al peptido beta-amiloide.
BR9106220A (pt) Antigenos sinteticos para a deterccao de anticorpos para o virus da hepatite c.
DK0538754T3 (da) Anvendelse af antistofholdige præparater til immunundertrykkelse
ES2076999T3 (es) Peptidos anticoagulantes radiomarcados.
ATE268382T1 (de) MENSCHLICHE-ßCDR-GRAFTEDß-ANTIKÖRPER GEGEN GANGLIOSID GM2
DK0845998T3 (da) Lægemidler til immunbehandling indeholdende antistoffer, der specifikt genkender MHCII-antigenet hos en patient, der skal behandles
EA200200974A1 (ru) Моноклональные антитела к рецептору лпнп человека, их получение и применение
EA200300939A1 (ru) Синтетические пептиды человека и фармацевтические композиции, содержащие их , для лечения системной красной волчанки
FI20095269A (fi) Lymfosyyttien sitoutumiseen vaikuttava ihmisen endoteelisolun molekyyli
ATE142648T1 (de) Antigerinnungspeptide
DK0646016T3 (da) Syntetiske peptider til behandlling af myasthenia gravis
PT951481E (pt) Utilizacao de substancias com accao imunomoduladora para o tratamento da esclerose lateral amiotrofica
BR9305525A (pt) Teste de anticorpos para amilina
ES2148248T3 (es) Peptidos de la lipoproteina (a) y su utilizacion.
GR1001050B (el) Νεος il-2 υποδοχευς ιδιαζοντων ανθρωπινων ανοσοσφαιρινων.
TH42174A3 (th) แอนติบอดีที่ทำให้เหมือนมนุษย์ซึ่งจำเพาะสำหรับ 4-1bb ของมนุษย์และสารผสมทางเภสัชกรรม ซึ่งประกอบด้วยสิ่งเดียวกัน
TH62172A (th) โมเลกุลยึดประสานที่ใช้บำบัดรักษา